The interaction of tissue-bound mCRP with anti-CRP antibodies in vascular tissue has been suggested to promote the production of atherosclerosis and could therefore link elevated anti-CRP serum levels with chronic vascular disease in SLE patients. Here, CRP is linked to systemic lupus erythematosus.